Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer

NCT03419130 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study withdrawn prior to patient enrollment

Conditions

Infiltrating Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
Stage III Bladder Urothelial Carcinoma AJCC v6 and v7

Interventions

RADIATION: Hypofractionated Radiation Therapy
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
RADIATION: Radiation Therapy

Sponsor

University of California, San Francisco

Collaborators

[object Object]